{"id":"W4386836949","doi":"10.1186/s13075-023-03128-1","title":"Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study","year":2023,"lang":"en","type":"article","venue":"Arthritis Research & Therapy","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Arthritis Society; University of Toronto; University Health Network","funders":"UCB Pharma; Celgene; Gilead Sciences; Eisai; Sanofi; Chugai Pharmaceutical; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Ankylosing spondylitis; Internal medicine; Placebo; Adverse effect; Rheumatology; BASFI; BASDAI; Rheumatoid arthritis; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001701627,0.000222735,0.0006854384,0.0002780096,0.0002837098,0.00004135413,0.0002735372,0.00007301875,0.0001008877],"category_scores_gemma":[0.0004307669,0.0001375408,0.00003529808,0.001257333,0.0003583813,0.0001256977,0.0002897081,0.000308429,0.000009643798],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005497273,"about_ca_system_score_gemma":0.00009874585,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002582778,"about_ca_topic_score_gemma":0.0004629931,"domain_scores_codex":[0.996803,0.0006156756,0.0006240313,0.0006466607,0.0007907295,0.0005198795],"domain_scores_gemma":[0.9973792,0.001156033,0.0001321869,0.000726108,0.0004597755,0.0001466997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2044561,0.01092124,0.1454727,0.000006657437,0.0004238361,0.0002703928,0.009291917,0.000001082652,0.005386382,0.00002827619,0.0006504428,0.623091],"study_design_scores_gemma":[0.2327201,0.03026131,0.7264994,0.0007783295,0.000007525342,0.000002133848,0.003186864,0.000003744823,0.0004496621,0.00006685674,0.005888321,0.0001357623],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892606,0.003586609,6.498605e-7,0.0006425772,0.00004148861,0.005057349,0.001210455,0.00002659719,0.0001736393],"genre_scores_gemma":[0.9823756,0.01671372,0.0001515251,0.0001122339,0.00003771698,0.0001441856,0.0003769041,0.00003514779,0.00005295149],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6229552,"threshold_uncertainty_score":0.5608749,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1138991202921506,"score_gpt":0.4035689931621553,"score_spread":0.2896698728700047,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}